Clifford Materials Reactivity Testing is intended as a screening test for systemic sensitivity to
materials used in patient care and is not a means of specific diagnosis or prognosis of any
disease or condition.
We have found that most people have come in contact with a sufficient variety of substances to develop their antibody record by the age of puberty. Because their antibody records are not fully mature, caution should be used when considering this kind of testing for children.
Patients with unusual environmental sensitivities may exhibit reactions which do not pass through the immune mechanisms. Targeted antibodies in these instances are not produced which reduces the effectiveness of our testing. In these rare instances provocative challenge testing may be helpful such as MELISA and ELISA/ACT tests.
While Clifford Materials Reactivity Testing is useful in detecting systemic sensitivies to chemical groups and materials for a patient, it does not address issues of mechanical performance or galvanic interaction between materials.
Our services are not approved for Medicare, Medicaid, MediCal or CHAMPUS participation and we do not accept insurance assignment. Testing charges are ultimately the responsibility of the patient.
Other factors to consider
patients may actually become immuno-tolerant of an antigen.
Adjuvant effects may occur with some constituents such as aluminum and mercury when chemical groups that the patient might normally handle well, react adversely due to amplification of their properties by the adjuvant. These reactivities often disappear over a period of months in longitudinal testing sequences when the adjuvants are removed from the body and lifestyle of the patient.
This may become a factor for temporization of sensitive patients with benign temporary materials for a period of months prior to final placement of long-term materials. It is not unusual to see some reactivity levels drop below detection limits, and even for some allergies to abate completely with adjuvant removal.
application of immuno-suppressive therapies or steroids